-
Most Popular
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
The 3 Best Growth Stocks to Buy in the Biotech Sector
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.
Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter Narcan
EBS stock is on the move as Emergent Biosciences expects its opioid emergency drug to be available soon without a prescription.
BMEA Stock: Biomea Fusion Pops on Public Offering News
Biomea Fusion (BMEA) stock is climbing higher on Wednesday after the company announced a public offering plan and continues a recent rally.
Why Is BiomX (PHGE) Stock Up 8% Today?
BiomX (PHGE) stock is rocketing on Wednesday following the release of the company's earnings report for the fourth quarter of 2022.
HRMY Stock Alert: Scorpion Short Report Sends Harmony Plunging
Scorpion Capital has issued a short report on HRMY stock, alleging that the company's Wakix drug is not safe for the public.
Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today?
Monopar Therapeutics (MNPR) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results.
Why Is Viking Therapeutics (VKTX) Stock Up 38% Today?
Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735.
Why Is Midatech Pharma (BDRX) Stock Up 64% Today?
Midatech Pharma (BDRX) stock is rocketing higher on Tuesday after the pharmaceutical company announced a new research program.
Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze
Short squeeze stocks are all over Wall Street in the wake of the regional banking crisis. Which names should you keep an eye out for?
Why Is Codiak BioSciences (CDAK) Stock Down 52% Today?
Codiak BioSciences (CDAK) stock is falling hard on Monday after the company announced plans for an asset sale through a Chapter 11 bankruptcy.
Why Is Unity Biotechnology (UBX) Stock Down 52% Today?
Unity Biotechnology (UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325.
Why Is NuCana (NCNA) Stock Down 36% Today?
NuCana (NCNA) stock is sliding lower on Monday after the company got an unfortunate patent update from the TBA of the EPO.
Why Is Coeptis Therapeutics (COEP) Stock Up 14% Today?
Coeptis Therapeutics (COEP) stock is climbing higher alongside heavy trading on Monday despite a lack of news from the drug company.
Why Is Allarity Therapeutics (ALLR) Stock Down 23% Today?
Allarity Therapeutics (ALLR) stock is sliding lower on Friday after announcing a reverse stock split happening later today.
Why Is Dermata Therapeutics (DRMA) Stock Up 23% Today?
Dermata Therapeutics (DRMA) stock is taking off on Friday despite a lack of news from the clinical-stage biotechnology company.
